Author:
Rutstein Sarah E.,Muessig Kathryn E.
Publisher
Springer Science and Business Media LLC
Reference91 articles.
1. Smith DK, Sullivan PS, Cadwell B, et al. Evidence of an association of increases in pre-exposure prophylaxis coverage with decreases in human immunodeficiency virus diagnosis rates in the United States, 2012–2016. Clin Infect Dis. 2020;71(12):3144–51.
2. Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. Core indicators for monitoring the Ending the HIV Epidemic initiative (preliminary data): National HIV Surveillance System data reported through June 2021; and preexposure prophylaxis (PrEP) data reported through March 2021. HIV Surveillance Data Tables 2021;2(No. 4). Table 3a. Number of Persons Prescribed PrEP, Number of Persons with PrEP Indications, and PrEP Coverage during January 2019 through March 2021, among Persons Aged >= 16 Years, by Selected Characteristics - United States (Preliminary). Published October 2021. https://www.cdc.gov/hiv/library/reports/surveillance-data-tables/vol-2-no-4/index.html. Accessed 4 May 2023.
3. Smith DK, Van Handel M, Wolitski RJ, et al. Vital signs: Estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition–United States, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(46):1291–5.
4. Siegler AJ, Bratcher A, Weiss KM. Geographic access to preexposure prophylaxis clinics among men who have sex with men in the United States. Am J Public Health. 2019;109(9):1216–23.
5. Sharpe JD, Guest JL, Siegler AJ, Sanchez TH, Sullivan PS. The spatiotemporal distribution of pre-exposure prophylaxis accessibility in the United States, 2016–2020. Ann Epidemiol. Published online September 24, 2021. https://doi.org/10.1016/j.annepidem.2021.09.006